Pharmacovigilance Volume 2
This book discusses various topics in pharmacovigilance. The first section addresses such topics as approaches to minimize adverse drug reactions, different stakeholders and their importance in pharmaceutical policy development, changing needs for pharmacovigilance in the African region, machine lea...
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_113223 | ||
| 005 | 20230905 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20230905s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a intechopen.100957 | ||
| 020 | |a 9781803561264 | ||
| 020 | |a 9781803561257 | ||
| 020 | |a 9781803561271 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.5772/intechopen.100957 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a MMG |2 bicssc | |
| 100 | 1 | |a Kothari, Charmy S. |4 edt | |
| 700 | 1 | |a Shah, Manan |4 edt | |
| 700 | 1 | |a Kothari, Charmy S. |4 oth | |
| 700 | 1 | |a Shah, Manan |4 oth | |
| 245 | 1 | 0 | |a Pharmacovigilance |b Volume 2 |
| 260 | |b IntechOpen |c 2023 | ||
| 300 | |a 1 electronic resource (124 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This book discusses various topics in pharmacovigilance. The first section addresses such topics as approaches to minimize adverse drug reactions, different stakeholders and their importance in pharmaceutical policy development, changing needs for pharmacovigilance in the African region, machine learning applications in pharmacovigilance, and pharmacovigilance of biological drugs. The second section discusses signal detection, which is a promising approach that helps in the early identification of new, rare drug reactions (desired or undesired). | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/3.0/ |2 cc |4 https://creativecommons.org/licenses/by/3.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Pharmacology |2 bicssc | |
| 653 | |a machine learning | ||
| 653 | |a data mining | ||
| 653 | |a elderly | ||
| 653 | |a biosimilar | ||
| 653 | |a supervised learning | ||
| 653 | |a mental disorders | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mts.intechopen.com/storage/books/11679/authors_book/authors_book.pdf |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/113223 |7 0 |z DOAB: description of the publication |